ST Calabash Brothers: Injection of zoledronic acid concentrated solution drug registration certificate approved

ST Huluo announcement, recently received the "Drug Registration Certificate" for the injection of zoledronic acid concentrated solution issued by the National Medical Products Administration. The indication of this drug is for use in combination with standard anti-tumor drugs for the treatment of bone metastases in solid tumor patients, multiple myeloma patients with bone damage, and hypercalcemia caused by malignant tumors. As of now, the company has invested a total of 4.0193 million yuan in research and development of this product.